Published online before print
September 13, 2006 Eur Respir J 2006, doi:10.1183/09031936.00045206
Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers
G. Tanaka 1,
A.J. Sandford 1*,
K. Burkett 1,
J.E. Connett 2,
N.R. Anthonisen 3,
P.D. Paré 1,
J-Q. He 1
1 James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
2 Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA
3 Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
* To whom correspondence should be addressed. E-mail: asandford{at}mrl.ubc.ca.
 |
Abstract |
|---|
Genetic variants in the tumour necrosis factor (TNF) gene have been investigated in chronic obstructive pulmonary disease (COPD). However there are many instances of non-replication of these associations and this might be due to insufficient power or other factors. In this study, we have examined a large number of subjects to elucidate whether genetic variations of TNF and/or lymphotoxin A (LTA), which is clustered with TNF, are associated with lung function in smokers. We designed two nested case-control studies in the National Heart, Lung, and Blood Institute Lung Health Study (LHS) which enrolled 5,887 smokers. The first design included continuous smokers who had the fastest (n=279) and the slowest (n=304) decline of lung function during the 5 year follow up period, and the second included the subjects who had the lowest (n=533) and the highest (n=532) post bronchodilator FEV1% predicted at the start of the LHS. We selected and genotyped 10 tagging SNPs within the TNF and LTA region. Unlike the previous associations between TNF-308 and COPD in Asians, we found no association between either of the two phenotypes and the LTA and TNF polymorphisms. These results support the findings of previous studies in late-onset COPD in Caucasian populations.
Keywords:
FEV1, lymphotoxin A, polymorphism, smoking, tumour necrosis factor
This article has been cited by other articles:

|
 |

|
 |
 
J. Smolonska, C. Wijmenga, D. S. Postma, and H. M. Boezen
Meta-analyses on Suspected Chronic Obstructive Pulmonary Disease Genes: A Summary of 20 Years' Research
Am. J. Respir. Crit. Care Med.,
October 1, 2009;
180(7):
618 - 631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Demoor, K. R. Bracke, T. Maes, B. Vandooren, D. Elewaut, C. Pilette, G. F. Joos, and G. G. Brusselle
Role of lymphotoxin-{alpha} in cigarette smoke-induced inflammation and lymphoid neogenesis
Eur. Respir. J.,
August 1, 2009;
34(2):
405 - 416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S J Marciniak and D A Lomas
What can naturally occurring mutations tell us about the pathogenesis of COPD?
Thorax,
April 1, 2009;
64(4):
359 - 364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J-Q. He, K. Shumansky, J. E. Connett, N. R. Anthonisen, P. D. Pare, and A. J. Sandford
Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD
Eur. Respir. J.,
July 1, 2008;
32(1):
25 - 34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Moghaddam, C. G. Clement, M. M. De la Garza, X. Zou, E. L. Travis, H. W. J. Young, C. M. Evans, M. J. Tuvim, and B. F. Dickey
Haemophilus influenzae Lysate Induces Aspects of the Chronic Obstructive Pulmonary Disease Phenotype
Am. J. Respir. Cell Mol. Biol.,
June 1, 2008;
38(6):
629 - 638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Gingo, L. J. Silveira, Y. E. Miller, A. L. Friedlander, G. P. Cosgrove, E. D. Chan, L. A. Maier, and R. P. Bowler
Tumour necrosis factor gene polymorphisms are associated with COPD
Eur. Respir. J.,
May 1, 2008;
31(5):
1005 - 1012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2007
Am. J. Respir. Crit. Care Med.,
April 15, 2008;
177(8):
820 - 829.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chappell, L. Daly, K. Morgan, T. G. Baranes, J. Roca, R. Rabinovich, A. Millar, S. C. Donnelly, V. Keatings, W. MacNee, et al.
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD
Eur. Respir. J.,
October 1, 2007;
30(4):
810 - 812.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J-Q. He, K. Shumansky, X. Zhang, J. E. Connett, N. R. Anthonisen, and A. J. Sandford
Polymorphisms of interleukin-10 and its receptor and lung function in COPD
Eur. Respir. J.,
June 1, 2007;
29(6):
1120 - 1126.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the European Respiratory Society.
|